Quest Diagnostics (DGX) Accumulated Expenses: 2010-2024
- Quest Diagnostics' Accumulated Expenses rose 6.62% to $306.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $306.0 million, marking a year-over-year increase of 6.62%. This contributed to the annual value of $306.0 million for FY2024, which is 6.62% up from last year.
- Latest data reveals that Quest Diagnostics reported Accumulated Expenses of $306.0 million as of Q4 2024, which was up 6.62% from $287.0 million recorded in Q4 2023.
- Over the past 5 years, Quest Diagnostics' Accumulated Expenses peaked at $460.0 million during Q4 2021, and registered a low of $287.0 million during Q4 2023.
- Moreover, its 3-year median value for Accumulated Expenses was $306.0 million (2024), whereas its average is $328.3 million.
- Its Accumulated Expenses has fluctuated over the past 5 years, first soared by 59.64% in 2020, then decreased by 26.79% in 2023.
- Quest Diagnostics' Accumulated Expenses (Quarterly) stood at $356.0 million in 2020, then rose by 29.21% to $460.0 million in 2021, then fell by 14.78% to $392.0 million in 2022, then declined by 26.79% to $287.0 million in 2023, then rose by 6.62% to $306.0 million in 2024.
- Its last three reported values are $306.0 million in Q4 2024, $287.0 million for Q4 2023, and $392.0 million during Q4 2022.
